RBC Capital Boosts Price Target on Regeneron Pharmaceuticals (NASDAQ:REGN) to $820 From $818By legume / August 4, 2023 / Regeneron Pharmaceuticals, Royal Bank of Canada RBC Capital Boosts Price Target on Regeneron Pharmaceuticals (NASDAQ:REGN) to $820 From $818, Keeps Sector Perform Rating.